Veropharm

Veropharm is a leading Russian pharmaceutical company, known domestically and internationally as one of the largest Russian manufacturers. Founded on January 21, 1997, the company comprises three plants, including the Voronezh chemical and pharmaceutical plant, Belgorod enterprise for the production of finished dosage forms, and the Pokrovsky plant for finished dosage forms. The company's portfolio is divided into three product groups: hospital drugs (prescription, oncological), and pharmacy drugs (prescription, over-the-counter, plasters, and medical devices). With a modern, dynamically developing production base and a team of highly professional specialists, Veropharm is constantly improving its research, production, and human potential to apply scientific achievements in its medicines. The company's portfolio consists of over 300 products used in various medical fields, and it employs 2000 qualified professionals. The team efficiently works to offer reasonable solutions, elevating the level of modern drug therapy, utilizing their unique knowledge and experience. Despite not having specific details about the headquarters, last investment, or investors, Veropharm stands as a prospective player in the pharmaceutical manufacturing industry, showcasing a robust track record and a bright future outlook.